Won-Kyo Jung | 'Marine algae, Ecklonia cava Extracts' … inhibitory effect on asthma
’Marine algae, Ecklonia cava Extracts’ … inhibitory effect on asthma
Professor Won-Kyo Jung The Dong-A Daily News attracted public attention by introducing representative marine bio research results. Professor Won-Kyo Jung of Pukyong National University (Department of Biomedical Engineering)’s research achievements were introduced in the Dong-A Daily News as a representative marine bio research achievement and attracted people’s attention. On the 30th of last month, the newspaper introduced that "the marine bio market, which uses natural substances extracted from marine organisms as medicines, is attracting public attention," and introduced the research results of three marine biologics, including Professor Won-Kyo Jung, Professor Cha Hyung-joon of POSTECH, and Dr. Choi Yong-doo of the National Cancer Center. The newspaper said, "The research team of Professor Won-Kyo Jung of the Department of Biomedical Engineering at Pukyong National University found that the Phlorotannin extracted from Ecklonia cava has the effect of suppressing asthma. Previously, an anticancer drug called mitomycin C was prescribed, but there were side effects such as vomiting, diarrhea, and a lower immune function. Ecklonia, which is used for food, can minimize these side effects, and it is expected that it can be used in various medical devices, such as vasoocclusion and airway obstruction."According to Professor Won-Kyo Jung, the research team (joint research of Pukyong National University and Kosin University) investigated the mechanism of suppression of asthma of seaweed Ecklonia cava extract and proved its effectiveness in animal models. Asthma refers to a phenomenon in which the respiratory tract becomes narrowed or blocked due to an inflammatory response. Professor Jung said, "The extract of Ecklonia cava, a natural material, is evaluated to be able to replace the existing market as it can minimize side effects such as a lower immune function, vomiting, and diarrhea compared to drugs previously used to prevent airway constriction." The results of this research were published in the ’International Journal of Tissue Engineering and Regenerative Medicine Society’, and intellectual property rights for the original technology were also secured through domestic and international patent applications and registrations (2017, 2019). This marine biomaterial, developed by Professor Jung’s research team, is expected to be applied in various ways to high value medical materials such as catheter, stent, and anti-adhesion.
7 January 2021
연구진정원교 wkjung@pknu.ac.kr공과대학 해양 의생명과학 연구실
